genomics
CancerTYPE ID Study Underscores Value of Knowing Tissue of Origin Amid Tissue-Agnostic Approvals
Premium
The use of BRAF inhibitors in patients with BRAF V600E mutations without identification of site of origin in CUP patients can lead to inappropriate therapy.
Faeth Therapeutics Closes $47M Series A Round to Explore Precision Diet Cancer Therapy Benefits
In clinical trials, the firm will screen patients for their tumors' nutritional vulnerabilities, and dispense a complete diet to be used alongside drugs.
Routine Genomic Profiling Could Improve Diagnosis of Aggressive Brain Cancers, Patient Outcomes
Premium
A study by UCSF researchers has shown the benefits of offering all brain cancer patients the chance to get genomic sequencing.
Multiple successor trials are in the works based on hits, misses, and overall knowledge gained from one of the first precision medicine platform trials.
Healthcare Stakeholders Redefine Cancer Multigene Testing Clinical Utility Hoping to Spur Adoption
Premium
The new definition factors in individual patients' outcomes, benefits to health systems, access to clinical trials, and shared decision making with patients.